Vanguard Fiduciary Trust
HURA

Vanguard Fiduciary Trust’s TuHURA Biosciences HURA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$588K Sell
251,186
-35,947
-13% -$83.7K ﹤0.01% 3221
2026
Q1 		$514K Buy
+287,133
New +$352K ﹤0.01% 3203

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust's HURA Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its TuHURA Biosciences (HURA) stake by 13% in Q2 2026, selling an estimated $83.7K and leaving 251,186 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #3221.

Vanguard Fiduciary Trust first reported a position in HURA in Q1 2026 and has held it in 2 quarters since. 83 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Vanguard Fiduciary Trust held 251,186 shares of TuHURA Biosciences worth $588K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 35,947 TuHURA Biosciences shares in Q2 2026, an estimated $83.7K.
  • TuHURA Biosciences made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3221 holding.
  • Vanguard Fiduciary Trust first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 83 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.